DarioHealth Company

DarioHealth is a digital health company. It is engaged in the development and commercialization of patented and proprietary technology that provides consumers with laboratory-testing capabilities using smartphones and other mobile devices. The company's product, Dario Blood sugar monitor is a mobile, real-time, cloud-based, diabetes management solution based on a multi-featured software application combined with a blood glucose monitoring device. The group operates internationally and derives revenues from the sale of its Dario smart meter and related device-specific disposables test strip cartridges and lancets. The company generates the majority of the revenue.
Industry: P4 Medicine
Headquarters: New York, New York, United States
Zip: 101-250
Founded Date: 2011-01-01
Employees Number: 101-250
Funding Status: IPO
Acquisitions Number: 10
Investors Number: 219003822
Total Funding: $1M to $10M
Estimated Revenue: 2013-04-09
Last Funding Date: Post-IPO Debt
Last Funding Type: info@mydario.com

Visit Website
Register and Claim Ownership